UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.11-31

2015

Volltextzugriff (PDF)

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.854-862

2014

Volltextzugriff (PDF)

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.32-39

2015

Volltextzugriff (PDF)

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2690-2697

2016

Volltextzugriff (PDF)

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

Blood, 2013-08, Vol.122 (6), p.981-987

2013

Volltextzugriff (PDF)

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4324-4332

2010

Volltextzugriff (PDF)

How I treat mycosis fungoides and Sézary syndrome

Blood, 2009-11, Vol.114 (20), p.4337-4353

2009

Volltextzugriff (PDF)

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

Journal of clinical oncology, 2013-02, Vol.31 (6), p.684-691

2013

Volltextzugriff (PDF)

Revised Response Criteria for Malignant Lymphoma

Journal of clinical oncology, 2007-02, Vol.25 (5), p.579-586

2007

Volltextzugriff (PDF)

Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

The New England journal of medicine, 2008-01, Vol.358 (4), p.362-368

2008

Volltextzugriff (PDF)

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Journal of the American Academy of Dermatology, 2015-02, Vol.72 (2), p.286-292

2015

Volltextzugriff (PDF)

Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital Lymphoma

International journal of radiation oncology, biology, physics, 2013-08, Vol.86 (5), p.930-935

2013

Volltextzugriff (PDF)

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Journal of clinical oncology, 2014-03, Vol.32 (9), p.912-918

2014

Volltextzugriff (PDF)

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood, 2007-07, Vol.110 (2), p.479-484

2007

Volltextzugriff (PDF)

How I treat nodular lymphocyte predominant Hodgkin lymphoma

Blood, 2013-12, Vol.122 (26), p.4182-4188

2013

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Blood, 2008-09, Vol.112 (5), p.1600-1609

2008

Volltextzugriff (PDF)

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.40-45

2015

Volltextzugriff (PDF)

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

Journal of clinical oncology, 2013-02, Vol.31 (5), p.592-598

2013

Volltextzugriff (PDF)

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

British journal of haematology, 2013-04, Vol.161 (1), p.76-86

2013

Volltextzugriff (PDF)

Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience

International journal of radiation oncology, biology, physics, 2016-08, Vol.95 (5), p.1454-1459

2016

Volltextzugriff (PDF)

Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease

Journal of clinical oncology, 2007-01, Vol.25 (1), p.43-49

2007

Volltextzugriff (PDF)

Protective Conditioning for Acute Graft-versus-Host Disease

The New England journal of medicine, 2005-09, Vol.353 (13), p.1321-1331

2005

Volltextzugriff (PDF)

Cd30 + cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma

Journal of the American Academy of Dermatology, 2003-12, Vol.49 (6), p.1049-1058

2003

Volltextzugriff (PDF)

Evolution of the techniques of radiation therapy in the management of lymphoma

International journal of clinical oncology, 2013-06, Vol.18 (3), p.359-363

Hoppe, Richard T.

2013

Volltextzugriff (PDF)

Technical report: 3D-printed patient-specific scalp shield for hair preservation in total skin electron beam therapy

Technical innovations & patient support in radiation oncology, 2021-06, Vol.18, p.12-15

2021

Volltextzugriff (PDF)

1 – 25 von 775

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(665)
Mit Volltextzugriff
(605)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(446)
Life Sciences & Biomedicine
(375)
Humans
(341)
Female
(197)
Male
(196)
Oncology
(161)
Middle Aged
(154)
Adult
(153)
Biological And Medical Sciences
(145)
Medical Sciences
(138)
Aged
(109)
Adolescent
(84)
Hematologic And Hematopoietic Diseases
(83)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(80)
Neoplasm Staging
(78)
Prognosis
(69)
Hematology
(68)
Radiology, Nuclear Medicine & Medical Imaging
(66)
Treatment Outcome
(60)
Physical Sciences
(59)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

How I treat mycosis fungoides and Sézary syndrome

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

Revised Response Criteria for Malignant Lymphoma

Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital Lymphoma

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

How I treat nodular lymphocyte predominant Hodgkin lymphoma

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience

Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease

Protective Conditioning for Acute Graft-versus-Host Disease

Cd30 + cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma

Evolution of the techniques of radiation therapy in the management of lymphoma

Technical report: 3D-printed patient-specific scalp shield for hair preservation in total skin electron beam therapy

Suchergebnisse filtern